Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1999;34:1032-1040

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correction (v36,p147)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Palmieri, V.
Right arrow Articles by Devereux, R. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Palmieri, V.
Right arrow Articles by Devereux, R. B.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*High Blood Pressure
Related Collections
Right arrow Obesity
Right arrow Other hypertension
Right arrow Hypertrophy
Right arrow Other etiology

(Hypertension. 1999;34:1032-1040.)
© 1999 American Heart Association, Inc.


Scientific Contributions

Ambulatory Blood Pressure and M;etabolic Abnormalities in Hypertensive Subjects With Inappropriately High Left Ventricular Mass

Vittorio Palmieri; Giovanni de Simone; Mary J. Roman; Joseph E. Schwartz; Thomas G. Pickering; Richard B. Devereux

From the Division of Cardiology and Hypertension Center, Department of Medicine, New York Presbyterian Hospital, Joan and Sanford I. Well Medical College of Cornell University, New York, NY.

Correspondence to Richard B. Devereux, MD, Division of Cardiology, Box 222, New York Presbyterian Hospital–Weill Medical College of Cornell University, 525 E 68th St, New York, NY 10021. E-mail rbdevere{at}mail.med.cornell.edu

Abstract—Appropriateness of left ventricular (LV) mass to cardiac workload can be evaluated by the ratio of observed LV mass to the value predicted for an individual’s gender, height2.7, and stroke work at rest (%PLVM). It is unclear which pathophysiological factors are associated with inappropriately high LV mass in hypertensive subjects. Adequate LV mass was defined by the 90% confidence interval (73% to 128%) of the distribution of %PLVM in 393 normal-weight normotensive subjects. In 185 hypertensive subjects (aged 56±11 years; 60% male, 29% black), according to %PLVM, 164 (88%) had adequate LV mass, 16 (9%) had inappropriately high LV mass (%PLVM >128%), and 5 (3%) had %PLVM <73% (low LV mass). Age, gender, smoking habit, proportion of never-treated subjects, total cholesterol, triglycerides, and creatinine levels did not differ significantly between subjects with adequate and inappropriately high LV mass. Body mass index, fasting glucose, and proportion of black subjects were higher (all P<0.05), while HDL cholesterol was lower (P<0.05) in subjects with inappropriately high LV mass. Blood pressure at the echocardiogram was comparable between subjects with adequate and inappropriately high LV mass, but the latter group had higher ambulatory blood pressure (P<0.01). Subjects with inappropriately high LV mass also had higher aortic root dimension and LV relative wall thickness and relatively lower LV systolic performance than those with adequate LV mass (all P<0.001). Larger aortic root diameter and lower systolic function were also found in hypertensive subjects with inappropriate LV hypertrophy compared with those with adequate LV hypertrophy. In an exploratory case-control study that compared subjects with low %PLVM with age-matched counterparts with adequate LV mass, low %PLVM was associated with lower body mass index, more favorable metabolic profile, and higher LV myocardial contractility. Higher body mass index, larger aortic root, and black race were independent correlates of increased %PLVM. Thus, in arterial hypertension, levels of LV mass inappropriately high for gender, cardiac workload, and height2.7 are associated with higher body mass index, higher ambulatory blood pressure, larger aortic root diameters, and relatively low myocardial contractility.


Key Words: hypertrophy, left ventricular • hypertension, white coat • obesity • metabolism • echocardiography




This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
E. R. Porrello, J. R. Bell, J. D. Schertzer, C. L. Curl, J. R. McMullen, K. M. Mellor, R. H. Ritchie, G. S. Lynch, S. B. Harrap, W. G. Thomas, et al.
Heritable pathologic cardiac hypertrophy in adulthood is preceded by neonatal cardiac growth restriction
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2009; 296(3): R672 - R680.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. L. Muiesan, M. Salvetti, A. Paini, C. Agabiti-Rosei, C. Monteduro, G. Galbassini, E. Belotti, C. Aggiusti, D. Rizzoni, M. Castellano, et al.
Inappropriate Left Ventricular Mass in Patients With Primary Aldosteronism
Hypertension, September 1, 2008; 52(3): 529 - 534.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
B. Lopez, J. M. Castellano, A. Gonzalez, J. Barba, and J. Diez
Association of Increased Plasma Cardiotrophin-1 With Inappropriate Left Ventricular Mass in Essential Hypertension
Hypertension, November 1, 2007; 50(5): 977 - 983.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. L. Muiesan, M. Salvetti, A. Paini, C. Monteduro, G. Galbassini, B. Bonzi, P. Poisa, E. Belotti, C. Agabiti Rosei, D. Rizzoni, et al.
Inappropriate Left Ventricular Mass Changes During Treatment Adversely Affects Cardiovascular Prognosis in Hypertensive Patients
Hypertension, May 1, 2007; 49(5): 1077 - 1083.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
Developed in Collaboration With the European Heart, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al.
ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death)
J. Am. Coll. Cardiol., September 5, 2006; 48(5): e247 - e346.
[Full Text] [PDF]


Home page
EuropaceHome page
Writing Committee Members, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al.
ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
Europace, September 1, 2006; 8(9): 746 - 837.
[Full Text] [PDF]


Home page
HypertensionHome page
M. C. C. Borges, R. C.R. Colombo, J. G. F. Goncalves, J. d. O. Ferreira, and K. G. Franchini
Longitudinal Mitral Annulus Velocities Are Reduced in Hypertensive Subjects With or Without Left Ventricle Hypertrophy
Hypertension, May 1, 2006; 47(5): 854 - 860.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. Berenji, M. H. Drazner, B. A. Rothermel, and J. A. Hill
Does load-induced ventricular hypertrophy progress to systolic heart failure?
Am J Physiol Heart Circ Physiol, July 1, 2005; 289(1): H8 - H16.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A.-K. Siegel, M. Planert, S. Rademacher, A. P. Mehr, P. Kossmehl, M. Wehland, M. Stoll, and R. Kreutz
Genetic Loci Contribute to the Progression of Vascular and Cardiac Hypertrophy in Salt-Sensitive Spontaneous Hypertension
Arterioscler Thromb Vasc Biol, July 1, 2003; 23(7): 1211 - 1217.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
C. Romano, M. Chinali, F. Pasanisi, R. Greco, A. Celentano, A. Rocco, V. Palmieri, A. Signorini, F. Contaldo, and G. de Simone
Reduced hemodynamic load and cardiac hypotrophy in patients with anorexia nervosa
Am. J. Clinical Nutrition, February 1, 2003; 77(2): 308 - 312.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. Kozakova, G. de Simone, C. Morizzo, and C. Palombo
Coronary Vasodilator Capacity and Hypertension-Induced Increase in Left Ventricular Mass
Hypertension, February 1, 2003; 41(2): 224 - 229.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
G. de Simone, P. Verdecchia, S. Pede, M. Gorini, and A. P. Maggioni
Prognosis of Inappropriate Left Ventricular Mass in Hypertension: The MAVI Study
Hypertension, October 1, 2002; 40(4): 470 - 476.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
S. B. Harrap, V. R. Danes, J. A. Ellis, C. D. Griffiths, E. F. Jones, and L. M. D. Delbridge
The hypertrophic heart rat: a new normotensive model of genetic cardiac and cardiomyocyte hypertrophy
Physiol Genomics, April 10, 2002; 9(1): 43 - 48.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
G. de Simone, F. Pasanisi, and F. Contaldo
Link of Nonhemodynamic Factors to Hemodynamic Determinants of Left Ventricular Hypertrophy
Hypertension, July 1, 2001; 38(1): 13 - 18.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
S. B. Harrap, V. R. Danes, J. A. Ellis, C. D. Griffiths, E. F. Jones, and L. M. D. Delbridge
The hypertrophic heart rat: a new normotensive model of genetic cardiac and cardiomyocyte hypertrophy
Physiol Genomics, April 10, 2002; 9(1): 43 - 48.
[Abstract] [Full Text] [PDF]